Low L-selectin as a risk factor for PML Multiple Sclerosis Research, 28 Aug 2015 Spadaro M, Caldano M, Marnetto F, Lugaresi A, Bertolotto A.Natalizumab treatment reduces L-selectin (CD62L) in CD4(+) T cells. J…